News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
603,007 Results
Type
Article (42869)
Company Profile (174)
Press Release (559950)
Multimedia
Podcasts (81)
Webinars (20)
Section
Business (161363)
Career Advice (2489)
Deals (29162)
Drug Delivery (126)
Drug Development (75583)
Employer Resources (142)
FDA (14094)
Job Trends (12895)
News (285446)
Policy (27855)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2615)
Academic (1)
Accelerated approval (43)
Adcomms (33)
Allergies (166)
Alliances (41239)
ALS (200)
Alzheimer's disease (1789)
Antibody-drug conjugate (ADC) (439)
Approvals (14411)
Artificial intelligence (618)
Autoimmune disease (258)
Automation (49)
Bankruptcy (316)
Best Places to Work (10401)
BIOSECURE Act (19)
Biosimilars (196)
Biotechnology (136)
Bladder cancer (180)
Brain cancer (66)
Breast cancer (702)
Cancer (5538)
Cardiovascular disease (458)
Career advice (2121)
Career pathing (42)
CAR-T (316)
CDC (54)
Celiac Disease (1)
Cell therapy (854)
Cervical cancer (40)
Clinical research (65696)
Collaboration (1888)
Company closure (6)
Compensation (837)
Complete response letters (83)
COVID-19 (2658)
CRISPR (102)
C-suite (1111)
Cystic fibrosis (133)
Data (7394)
Decentralized trials (3)
Denatured (13)
Depression (169)
Dermatology (74)
Diabetes (562)
Diagnostics (6303)
Digital health (43)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (294)
Drug pricing (185)
Drug shortages (27)
Duchenne muscular dystrophy (276)
Earnings (61984)
Editorial (63)
Employer branding (18)
Employer resources (134)
Events (89653)
Executive appointments (1080)
FDA (17514)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1549)
Gene editing (218)
Generative AI (57)
Gene therapy (706)
GLP-1 (1031)
Government (4471)
Grass and pollen (7)
Guidances (400)
Healthcare (16441)
HIV (78)
Huntington's disease (56)
IgA nephropathy (93)
Immunology and inflammation (306)
Immuno-oncology (87)
Indications (163)
Infectious disease (2985)
Inflammatory bowel disease (208)
Inflation Reduction Act (13)
Influenza (131)
Intellectual property (276)
Interviews (529)
IPO (13316)
IRA (50)
Job creations (2817)
Job search strategy (1707)
JPM (57)
Kidney cancer (20)
Labor market (71)
Layoffs (525)
Leadership (43)
Legal (5971)
Liver cancer (101)
Longevity (27)
Lung cancer (752)
Lymphoma (411)
Machine learning (55)
Management (51)
Manufacturing (889)
MASH (196)
Medical device (11091)
Medtech (11167)
Mergers & acquisitions (16972)
Metabolic disorders (1448)
mRNA (188)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (403)
Neuropsychiatric disorders (112)
Neuroscience (3259)
Neurotech (1)
NextGen: Class of 2026 (5708)
Non-profit (4074)
Now hiring (64)
Obesity (663)
Opinion (299)
Ovarian cancer (205)
Pain (243)
Pancreatic cancer (285)
Parkinson's disease (348)
Partnered (29)
Patents (562)
Patient recruitment (637)
Peanut (59)
People (55402)
Pharmaceutical (26)
Pharmacy benefit managers (19)
Phase 1 (20495)
Phase 2 (28950)
Phase 3 (21748)
Pipeline (7629)
Policy (304)
Postmarket research (2339)
Preclinical (8512)
Press Release (65)
Prostate cancer (280)
Psychedelics (60)
Radiopharmaceuticals (290)
Rare diseases (1026)
Real estate (4668)
Recruiting (61)
Regulatory (22415)
Reports (33)
Research institute (2265)
Resumes & cover letters (362)
Rett syndrome (35)
RNA editing (21)
RSV (80)
Schizophrenia (179)
Series A (265)
Series B (194)
Service/supplier (6)
Sickle cell disease (113)
Special edition (20)
Spinal muscular atrophy (167)
Sponsored (43)
Startups (3085)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (77)
The Weekly (66)
Vaccines (1030)
Venture capital (100)
Weight loss (441)
Women's health (102)
Worklife (22)
Date
Today (179)
Last 7 days (701)
Last 30 days (2590)
Last 365 days (28000)
2026 (9644)
2025 (27896)
2024 (32043)
2023 (35745)
2022 (46409)
2021 (49884)
2020 (48044)
2019 (41003)
2018 (31074)
2017 (28223)
2016 (27011)
2015 (31459)
2014 (23955)
2013 (19526)
2012 (20906)
2011 (21902)
2010 (19580)
Location
Africa (773)
Alabama (86)
Alaska (4)
Arizona (249)
Arkansas (13)
Asia (37267)
Australia (7537)
California (11257)
Canada (3432)
China (1263)
Colorado (461)
Connecticut (479)
Delaware (357)
Europe (83570)
Florida (1764)
Georgia (347)
Hawaii (3)
Idaho (56)
Illinois (926)
India (86)
Indiana (519)
Iowa (18)
Japan (491)
Kansas (120)
Kentucky (40)
Louisiana (36)
Maine (59)
Maryland (1395)
Massachusetts (8012)
Michigan (313)
Minnesota (601)
Mississippi (5)
Missouri (134)
Montana (30)
Nebraska (25)
Nevada (127)
New Hampshire (81)
New Jersey (3115)
New Mexico (22)
New York (3055)
North Carolina (1422)
North Dakota (8)
Northern California (5543)
Ohio (326)
Oklahoma (16)
Oregon (32)
Pennsylvania (2260)
Puerto Rico (27)
Rhode Island (41)
South America (1057)
South Carolina (79)
South Dakota (2)
Southern California (4521)
Tennessee (176)
Texas (1861)
United States (40170)
Utah (355)
Vermont (1)
Virginia (278)
Washington D.C. (69)
Washington State (981)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
603,007 Results for "chrysalis biotherapeutics formerly known as chrysalis biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego.
May 6, 2024
·
2 min read
Press Releases
Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
November 18, 2024
·
2 min read
Drug Development
Chrysalis Receives FDA Approval to Initiate Clinical Trials with Chrysalin™ (TP508)
Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.
September 26, 2023
·
2 min read
Press Releases
Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
April 21, 2026
·
5 min read
Press Releases
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
·
3 min read
Press Releases
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
April 2, 2026
·
4 min read
Press Releases
Stealth BioTherapeutics to Present Clinical Data for Bevemipretide Eye Drops at the Association for Research in Vision and Ophthalmology 2026 Annual Meeting
April 27, 2026
·
4 min read
Press Releases
EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting
April 15, 2026
·
1 min read
Press Releases
Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06, 5T4-Targeted Antibody Drug Conjugate, at the American Association for Cancer Research Annual Meeting
April 20, 2026
·
4 min read
Press Releases
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
April 7, 2026
·
4 min read
1 of 60,301
Next
